IsoPlexis to Report Second Quarter 2022 Financial Results on August 10, 2022
July 21 2022 - 7:00AM
IsoPlexis Corporation (Nasdaq: ISO), the Superhuman Cell Company,
today announced it will report financial results for the second
quarter 2022 before market open on Wednesday, August 10, 2022.
Company management will be webcasting a corresponding conference
call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time.
Live audio of the webcast will be available on the “Investors”
section of the company website at: www.isoplexis.com. The webcast
will be archived and available for replay after the event.
About IsoPlexisIsoPlexis is the Superhuman Cell
company.
By leading the discovery and identification of how
multi-functional immune— Superhuman— cells communicate and respond,
IsoPlexis assists researchers in understanding and predicting
disease progression, treatment resistance and therapeutic
efficacy.
IsoPlexis has been named Top Innovation or Design by The
Scientist Magazine, Fierce, BIG Innovation, Red Dot and multiple
others. The IsoPlexis platform is used globally by researchers,
including those at the top 15 global pharmaceutical companies by
revenue and at over 70% of leading U.S. comprehensive cancer
centers.
Investor Contactinvestors@isoplexis.com
Press Contactpress@isoplexis.com
IsoPlexis (NASDAQ:ISO)
Historical Stock Chart
From Jun 2024 to Jul 2024
IsoPlexis (NASDAQ:ISO)
Historical Stock Chart
From Jul 2023 to Jul 2024